American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Neumora Therapeutics’ (NMRA) “Outperform” Rating Reaffirmed at Royal Bank of Canada

Neumora Therapeutics’ (NMRA) “Outperform” Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research report released on Thursday, Benzinga reports. They currently have a $31.00 target price on... More of this article »
Image about Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price... More of this article »
Image about UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

MarketWise (NASDAQ:MKTW – Free Report) had its price target decreased by UBS Group from $3.50 to $2.00 in a report released on Thursday morning, Benzinga reports. UBS Group currently has a neutral rating on the newsletter publisher’s... More of this article »
Image about Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Chardan Capital restated their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report released on Thursday, Benzinga reports. Chardan Capital currently has a $21.00 price target on the stock. A number... More of this article »
Image about Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Craig Hallum upgraded shares of Lands’ End (NASDAQ:LE – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. The brokerage currently has... More of this article »
Image about Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a research report sent to investors on Thursday morning. A number of other research analysts have also issued reports on... More of this article »
Image about Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

StockNews.com upgraded shares of Limbach (NASDAQ:LMB – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday morning. Limbach Price Performance Limbach stock opened at $41.42 on Thursday. Limbach... More of this article »
Image about Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Royal Bank of Canada assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report report published on Thursday morning, MarketBeat Ratings reports. The firm issued an outperform rating and... More of this article »
Image about Iris Energy (NASDAQ:IREN) Receives Overweight Rating from Cantor Fitzgerald

Iris Energy (NASDAQ:IREN) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Iris Energy (NASDAQ:IREN – Free Report) in a report published on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $10.00 price target on the stock. Several... More of this article »
Image about Canaccord Genuity Group Reaffirms Buy Rating for Hut 8 (NASDAQ:HUT)

Canaccord Genuity Group Reaffirms Buy Rating for Hut 8 (NASDAQ:HUT)

Canaccord Genuity Group reissued their buy rating on shares of Hut 8 (NASDAQ:HUT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. Canaccord Genuity Group currently has a $3.50 target price... More of this article »
Image about Robinhood Markets (NASDAQ:HOOD) Receives Market Outperform Rating from JMP Securities

Robinhood Markets (NASDAQ:HOOD) Receives Market Outperform Rating from JMP Securities

JMP Securities reiterated their market outperform rating on shares of Robinhood Markets (NASDAQ:HOOD – Free Report) in a report issued on Thursday, Benzinga reports. They currently have a $25.00 price target on the stock. Other... More of this article »
Image about Hut 8 (NASDAQ:HUT) Given New $9.00 Price Target at HC Wainwright

Hut 8 (NASDAQ:HUT) Given New $9.00 Price Target at HC Wainwright

Hut 8 (NASDAQ:HUT – Free Report) had its price objective hoisted by HC Wainwright from $7.00 to $9.00 in a research note released on Thursday morning, Benzinga reports. HC Wainwright currently has a sell rating on the stock. HUT... More of this article »
Image about Canaccord Genuity Group Reaffirms “Buy” Rating for HIVE Digital Technologies (NASDAQ:HIVE)

Canaccord Genuity Group Reaffirms “Buy” Rating for HIVE Digital Technologies (NASDAQ:HIVE)

Canaccord Genuity Group reiterated their buy rating on shares of HIVE Digital Technologies (NASDAQ:HIVE – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price... More of this article »
Image about GDS (NASDAQ:GDS) PT Lowered to $7.00 at JPMorgan Chase & Co.

GDS (NASDAQ:GDS) PT Lowered to $7.00 at JPMorgan Chase & Co.

GDS (NASDAQ:GDS – Free Report) had its price target lowered by JPMorgan Chase & Co. from $12.00 to $7.00 in a research report sent to investors on Thursday, Benzinga reports. The brokerage currently has a neutral rating... More of this article »
Image about HC Wainwright Reiterates “Buy” Rating for Erasca (NASDAQ:ERAS)

HC Wainwright Reiterates “Buy” Rating for Erasca (NASDAQ:ERAS)

HC Wainwright restated their buy rating on shares of Erasca (NASDAQ:ERAS – Free Report) in a report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $8.00 target price on the stock. A number of... More of this article »